[HTML][HTML] Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study

CM Kozma, AL Paris, CA Plauschinat, T Slaton… - BMC Pulmonary …, 2011 - Springer
Background The purpose of this analysis was to compare health care costs and utilization
among COPD patients who had long-acting beta-2 agonist (LABA) OR long-acting …

[PDF][PDF] Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study

CM Kozma, AL Paris, CA Plauschinat, T Slaton… - 2011 - researchgate.net
Background: The purpose of this analysis was to compare health care costs and utilization
among COPD patients who had long-acting beta-2 agonist (LABA) OR long-acting …

[PDF][PDF] Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study

CM Kozma, AL Paris, CA Plauschinat, T Slaton… - 2011 - cyberleninka.org
Background: The purpose of this analysis was to compare health care costs and utilization
among COPD patients who had long-acting beta-2 agonist (LABA) OR long-acting …

Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study.

CM Kozma, AL Paris, CA Plauschinat… - BMC Pulmonary …, 2011 - europepmc.org
Background The purpose of this analysis was to compare health care costs and utilization
among COPD patients who had long-acting beta-2 agonist (LABA) OR long-acting …

[HTML][HTML] Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study

CM Kozma, AL Paris, CA Plauschinat… - BMC Pulmonary …, 2011 - ncbi.nlm.nih.gov
Background The purpose of this analysis was to compare health care costs and utilization
among COPD patients who had long-acting beta-2 agonist (LABA) OR long-acting …

Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study

CM Kozma, AL Paris, CA Plauschinat, T Slaton… - 2011 - pubmed.ncbi.nlm.nih.gov
Background The purpose of this analysis was to compare health care costs and utilization
among COPD patients who had long-acting beta-2 agonist (LABA) OR long-acting …

[HTML][HTML] Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study

CM Kozma, AL Paris… - BMC …, 2011 - bmcpulmmed.biomedcentral.com
The purpose of this analysis was to compare health care costs and utilization among COPD
patients who had long-acting beta-2 agonist (LABA) OR long-acting muscarinic antagonist …

Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study

CM Kozma, AL Paris, CA Plauschinat… - BMC Pulmonary …, 2011 - search.proquest.com
Background: The purpose of this analysis was to compare health care costs and utilization
among COPD patients who had long-acting beta-2 agonist (LABA) OR long-acting …

[PDF][PDF] Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study

CM Kozma, AL Paris, CA Plauschinat, T Slaton… - 2011 - Citeseer
Background: The purpose of this analysis was to compare health care costs and utilization
among COPD patients who had long-acting beta-2 agonist (LABA) OR long-acting …

Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study

CM Kozma, AL Paris, CA Plauschinat… - BMC Pulmonary …, 2011 - go.gale.com
Background The purpose of this analysis was to compare health care costs and utilization
among COPD patients who had long-acting beta-2 agonist (LABA) OR long-acting …